The Importance of a Wellbeing Check at UKSONO Healthcare
Many health conditions develop quietly long before symptoms appear. A structured wellbeing assessment can help you identify potential issues early, understand your baseline health, and make informed decisions with clinical guidance.
Earlier insight, better choices
Preventive checks can provide timely information to guide lifestyle changes, follow-up with your GP, and—where needed—earlier referral pathways.
Early diagnosis saves lives
In a public message supporting Stand Up To Cancer, King Charles III said: “Early diagnosis quite simply saves lives.” (12 December 2025)
Imaging + biomarkers + GP review
UKSONO’s wellbeing checks combine targeted ultrasound assessment with comprehensive blood biomarkers and a short GP consultation.
Why proactive wellbeing checks are increasingly important
Evidence from public health bodies and major cancer organisations consistently shows that earlier detection can improve outcomes and expand treatment options for many serious conditions. For example, Cancer Research UK highlights large differences in survival when bowel cancer is diagnosed early versus late. In England, around 9 in 10 people survive five years or more when bowel cancer is diagnosed at the earliest stage, compared with around 1 in 10 when diagnosed at the latest stage.
While not every condition can be prevented, structured checks can help you:
- understand your current health baseline (your “starting point”)
- identify potential issues that may benefit from timely GP review
- monitor trends over time, especially for metabolic, thyroid, lipid and inflammatory markers
- support informed lifestyle changes (diet, activity, sleep, alcohol intake, stress management)
One coordinated service — delivered with trusted clinical partners
UKSONO Healthcare provides your comprehensive health assessment and clinical oversight. Where blood testing is required, samples are performed at one of our approved partner locations, conveniently arranged close to your address for ease and accessibility.
| Component | What you get | Why it’s useful |
|---|---|---|
| Full body ultrasound scan | Sex-specific scan set (see below) | Non-invasive imaging assessment of key organs and soft tissues |
| 57 blood biomarkers | Comprehensive panels (FBC, thyroid, lipids, liver, kidney, inflammation, hormones, micronutrients) | Builds a broad metabolic and physiological overview; supports follow-up planning |
| 15-minute online GP video consultation | Clinical discussion of results and next steps | Helps interpret findings in context and plan appropriate onward actions |
Full body ultrasound scan — what we assess (and what it can show)
Ultrasound uses sound waves (not ionising radiation) to visualise organs and soft tissues. It can help identify structural changes such as cysts, stones, masses, organ enlargement, inflammation patterns, and urinary obstruction—depending on the region scanned. Below is a patient-friendly overview of what each component assesses.
Regions covered
- Neck lymph nodes
- Thyroid gland
- Salivary glands
- Abdomen (liver, gallbladder, pancreas region, spleen region)
- Urinary tract (kidneys + bladder)
- Prostate
What each region assesses
Neck: assesses lymph nodes for size/shape changes that can occur with infection, inflammation, or other causes.
Thyroid: assesses for nodules, cysts, goitre/enlargement and inflammatory patterns; some findings may require GP follow-up or further tests.
Salivary glands: assesses for stones, inflammation, cysts or masses.
Abdomen:
- Liver: can assess for cysts, focal lesions (e.g., benign-appearing lesions), fatty change patterns, inflammation patterns, and general size changes.
- Gallbladder: can assess for stones, sludge, polyps and inflammation patterns.
- Pancreas region: assessment is limited by bowel gas, but can sometimes identify larger structural abnormalities.
- Spleen region: assesses for enlargement and focal lesions.
Urinary tract: assesses kidneys for cysts, stones and obstruction; bladder wall and bladder emptying can also be assessed.
Prostate: assesses size and structural appearance; findings can be discussed with a GP in context of symptoms.
Regions covered
- Abdomen (liver, gallbladder, pancreas region, spleen region)
- Pelvis (uterus + ovaries)
- Neck lymph nodes
- Thyroid gland
- Salivary glands
- Urinary tract (kidneys + bladder)
- Optional breast ultrasound (Wellbeing Premium)
What each region assesses
Abdomen:
- Liver: can assess for cysts, focal lesions, fatty change patterns, inflammation patterns, and size changes.
- Gallbladder: can assess for stones, polyps and inflammation patterns.
- Pancreas region: assessment may be limited by bowel gas, but can sometimes identify larger structural abnormalities.
- Spleen region: assesses for enlargement and focal lesions.
Pelvis: assesses uterine size/shape, fibroids, endometrial appearance (cycle-dependent), ovarian appearance and cysts; findings are always interpreted in clinical context.
Neck/thyroid/salivary glands: as above—assessing for nodules, cysts, stones, inflammation patterns or masses.
Urinary tract: assesses kidneys for cysts, stones and obstruction; bladder wall and emptying can also be assessed.
Optional breast ultrasound: can assess focal breast concerns and benign features such as cysts; any abnormal findings may require onward pathway advice.
57 blood biomarkers — what your panel covers
Your blood biomarkers provide a broad physiological overview.
Measures red and white blood cells, haemoglobin and platelets to support assessment of conditions such as anaemia, infections and some blood disorders.
- White Blood Cell Count (WBC)
- Red Blood Cell Count (RBC)
- Haemoglobin (HGB)
- Hematocrit (HCT)
- Mean Corpuscular Volume (MCV)
- Mean Corpuscular Haemoglobin (MCH)
- Mean Corpuscular Haemoglobin Concentration (MCHC)
- Red Cell Distribution Width (RDW)
- Platelets (PLT)
- Mean Platelet Volume (MPV)
- Lymphocytes (LYM)
- Monocytes (MON)
- Neutrophils (NEU)
- Eosinophils (EOS)
- Basophils (BAS)
Assesses thyroid activity to support identification of underactive or overactive thyroid patterns.
- Unbound thyroxine (Free T4)
- Unbound triiodothyronine (Free T3)
- Thyroid Stimulating Hormone (TSH)
Measures average blood glucose over the prior 2–3 months.
- HbA1c
Assesses nutrients that support energy, immunity and overall wellbeing.
- Total Vitamin B12 (clinic only)
- Folate serum (clinic only)
- Ferritin
- Iron
- Transferrin
Markers that may be relevant for inflammation, recovery and overall physiological stress.
- C-Reactive Protein (CRP)
- Creatine Kinase (CK)
Supports assessment of kidney filtration and metabolic balance.
- Creatinine
- eGFR (CKD-EPI 2009 formula)
- Urea
- Uric acid
Assesses liver enzymes, proteins and bilirubin to support evaluation of liver health.
- Globulin calculation
- Albumin
- Total protein
- Bilirubin
- Alanine AminoTransferase (ALT)
- Gamma-GlutamylTransferase (GGT)
- Alkaline Phosphatase (ALP)
Helps assess cardiovascular risk and metabolic health.
- LDL cholesterol
- Non-HDL cholesterol
- HDL cholesterol
- Total cholesterol
- Total cholesterol/HDL ratio
- Triglycerides
Supports assessment of hydration status, nerve function and muscle function.
- Magnesium
Supports assessment of hormonal balance, stress physiology and reproductive health markers.
- Sex Hormone Binding Globulin (SHBG)
- Free Androgen Index (FAI)
- Oestradiol/estrogen (clinic only)
- Luteinizing Hormone (LH)
- Follicle Stimulating Hormone (FSH)
- Testosterone
- Free Testosterone
- Testosterone : Free Testosterone Ratio
- Testosterone : Cortisol Ratio
- Prolactin
- Cortisol
- DHEA Sulphate
Your 15-minute GP consultation helps you interpret results and agree next steps. Where appropriate, the GP may advise:
- reassurance and monitoring
- lifestyle optimisation and retesting intervals
- GP follow-up (especially for symptoms)
- additional imaging or specialist referral, when clinically indicated
Tip: Keep a copy of your results as a baseline for future comparisons. Consider repeating at a sensible interval based on risk profile and GP advice.
Book your wellbeing check
Choose the wellbeing check that fits your needs:
Sources referenced for the King’s quote and key early-diagnosis evidence:
- The Royal Household. A message from The King in support of Stand Up To Cancer (12 December 2025). royal.uk
- Cancer Research UK. Why is early cancer diagnosis important? (includes bowel cancer survival by stage). cancerresearchuk.org
- Cancer Research UK. Survival | Bowel cancer (England stage survival, 2016–2020). cancerresearchuk.org
- Wise J. New bowel cancer screening test is recommended for England. BMJ (2016). bmj.com
- UK Government / Public Health. Health matters: improving the prevention and detection of bowel cancer (27 June 2016). gov.uk
This article is for general information and does not replace personalised medical advice. For urgent symptoms, seek urgent care.
